1. Home
  2. AMCX vs RNAC Comparison

AMCX vs RNAC Comparison

Compare AMCX & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMCX
  • RNAC
  • Stock Information
  • Founded
  • AMCX 1980
  • RNAC 2007
  • Country
  • AMCX United States
  • RNAC United States
  • Employees
  • AMCX N/A
  • RNAC N/A
  • Industry
  • AMCX Cable & Other Pay Television Services
  • RNAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMCX Telecommunications
  • RNAC Health Care
  • Exchange
  • AMCX Nasdaq
  • RNAC Nasdaq
  • Market Cap
  • AMCX 375.2M
  • RNAC 422.4M
  • IPO Year
  • AMCX 2011
  • RNAC 2016
  • Fundamental
  • Price
  • AMCX $9.37
  • RNAC $19.02
  • Analyst Decision
  • AMCX Hold
  • RNAC Strong Buy
  • Analyst Count
  • AMCX 3
  • RNAC 8
  • Target Price
  • AMCX $9.33
  • RNAC $41.67
  • AVG Volume (30 Days)
  • AMCX 645.8K
  • RNAC 161.9K
  • Earning Date
  • AMCX 02-07-2025
  • RNAC 11-07-2024
  • Dividend Yield
  • AMCX N/A
  • RNAC N/A
  • EPS Growth
  • AMCX N/A
  • RNAC N/A
  • EPS
  • AMCX 0.79
  • RNAC N/A
  • Revenue
  • AMCX $2,500,857,000.00
  • RNAC $47,938,000.00
  • Revenue This Year
  • AMCX N/A
  • RNAC $56.06
  • Revenue Next Year
  • AMCX N/A
  • RNAC N/A
  • P/E Ratio
  • AMCX $11.90
  • RNAC N/A
  • Revenue Growth
  • AMCX N/A
  • RNAC N/A
  • 52 Week Low
  • AMCX $7.08
  • RNAC $11.67
  • 52 Week High
  • AMCX $19.55
  • RNAC $41.87
  • Technical
  • Relative Strength Index (RSI)
  • AMCX 50.90
  • RNAC 47.25
  • Support Level
  • AMCX $9.13
  • RNAC $16.70
  • Resistance Level
  • AMCX $9.99
  • RNAC $19.98
  • Average True Range (ATR)
  • AMCX 0.46
  • RNAC 2.39
  • MACD
  • AMCX -0.06
  • RNAC -0.37
  • Stochastic Oscillator
  • AMCX 34.62
  • RNAC 23.67

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached nearly 65 million pay-TV households in the US at the end of 2023. The firm also had nearly 11.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: